Rufinamide

Overview

Rufinamide is an anticonvulsant medication used in the treatment of Lennox-Gastaut syndrome, a severe form of childhood epilepsy. It works by preventing the repetitive firing of sodium-dependent action potentials in brain cells.

API suppliers (2)

Suppliers of Rufinamide backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

• Dipharma Francis SrlItaly1 active DMF
• Zhejiang Hisun Pharmaceutical Co., Ltd.China

Therapeutic areas